Nele De Meulenaere
YOU?
Author Swipe
View article: Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies
Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies Open
Pleural mesothelioma (PM) is a rare and aggressive cancer that often requires multiple diagnostic procedures before a definitive diagnosis can be made. To improve diagnostic accuracy, we developed a DNA methylation‐based biomarker assay ca…
View article: Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies
Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies Open
Pleural mesothelioma (PM) is a rare and aggressive cancer that often requires multiple diagnostic procedures before a definitive diagnosis can be made. To improve diagnostic accuracy, we developed a DNA methylation‐based biomarker assay ca…
View article: Genome-wide DNA methylation analysis reveals a unique methylation pattern for pleural mesothelioma compared to healthy pleura and other lung diseases
Genome-wide DNA methylation analysis reveals a unique methylation pattern for pleural mesothelioma compared to healthy pleura and other lung diseases Open
View article: Simultaneous detection of eight cancer types using a multiplex droplet digital <scp>PCR</scp> assay
Simultaneous detection of eight cancer types using a multiplex droplet digital <span>PCR</span> assay Open
DNA methylation biomarkers have emerged as promising tools for cancer detection. Common methylation patterns across tumor types allow multi‐cancer detection. Droplet digital PCR (ddPCR) has gained considerable attention for methylation det…